Gene study sheds light on causes of childhood sight loss

Image
ANI New Delhi [India]
Last Updated : May 18 2017 | 5:57 PM IST

A genetic mutation that contributes to sight loss in children has been identified by scientists.

The work has been published in the journal Human Mutation.

The mutation was identified in patients with a disease known as ocular coloboma, which causes part of the eye to be missing at birth.

The findings shed light on its causes and help to explain how genes contribute to development of the eye, researchers say.

Ocular coloboma accounts for up to 10 per cent of all childhood blindness. It can cause a distinctive keyhole-shaped pupil as it commonly results in a missing segment in the iris, the coloured part of the eye.

Few genetic causes have so far been found to explain the cause of coloboma.

The research team - lead by the University of Edinburgh - worked with 12 families, studying the DNA of children with coloboma and their unaffected parents.

Using state-of-the-art genetic screening - known as whole exome sequencing - the scientists revealed mutations in 10 genes, three of which were linked to activity of one molecule.

The molecule - known as actin - is important to a number of vital cell functions, including maintenance of the cytoskeleton, which defines cell shape and structure.

Targeted gene sequencing was then carried out on a further 380 people with coloboma. This showed that one of the mutations - a specific alteration in the gene ACTG1 - recurred across a number of those tested.

The scientists edited this ACTG1 mutation into a line of mice using cutting-edge CRISPR/Cas9 gene-editing technology, and found that it had severe effects on the function of actin.

The newly-identified mutations are thought to affect how actin binds to other proteins and on actin stability, which could severely affect development of the eye in the womb, scientists say.

Dr Joe Rainger, Fight for Sight Early Career Investigator Fellow at the University of Edinburgh's Roslin Institute and Royal (Dick) School of Veterinary Studies, said: "Coloboma can have profound effects on visual ability, but it is very variable and therefore likely to be caused by a number of genes. Our work adds knowledge to our understanding of its onset as well as the importance of actin to eye development."

The work was carried out at the University of Edinburgh's Institute for Genetics and Molecular Medicine and the Roslin Institute. The study was funded by eye research charity Fight for Sight.

George McNamara, Director of Research, Policy and Innovation at Fight for Sight, said: "Sight loss due to coloboma in children can be devastating. Very little is known about the cause, and this study has helped advance our knowledge about the development of the eye. As this work progresses, we have the opportunity to come closer to understanding the causes of childhood sight loss.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 18 2017 | 5:02 PM IST

Next Story